Followers | 144 |
Posts | 27707 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Wednesday, April 29, 2020 2:04:52 AM
Preface:
The project is a universal vaccine for the disease, which should protect against all influenza virus strains with one injection. The vaccine has been developing for about 15 years at BiondVax, which is headed by Dr. Ron Bakovov. Company Clinicians. The vaccine is currently in its final phase 3 trial, which includes a clinical trial in a large number of people. If the trial is successfully launched later this year and the vaccine is approved for use, it could replace the seasonal flu vaccine given annually, valid for only a few months and based on a World Health Organization informed guess of the influenza strains that will infect next year. The new vaccine will line up with him and not a lot of money.
Q/Do you think a vaccine for Corona will make sense in a year and a half?
A/"Developing a vaccine for Corona will take time, even if they decide to shorten processes because of public pressure. It's not something that is done in two months. Each vaccine needs to be tested and proven, and it takes many months. "There are no miracle cures to address the current outbreak. They may be able to develop a vaccine or cure by next winter. There are masses of scientists and groups in biotech companies that are making great efforts in this direction, and I hope at least one of them will succeed."
Q/Why is it that the vaccine you are working on for the flu has taken more than 20 years, and this too, in case you manage to get the approval soon?
A/"In the case of influenza, we went for something completely different from the corona vaccine. The influenza virus is seasonal: it arrives in winter, disappears in late spring, and returns again in the following winter. In a given year, it will not be effective against the virus of the following year.
Q/If the vaccine manages to protect us from violent strains of the flu, could it prevent the next epidemic?
A/"Yes. If it is proven effective. Remember that we do not yet have the results of the significant clinical trial. Everyone is now busy with Corona and the number of dead, but every year, hundreds of thousands of people die in the world, and it can reach 650,000 dead worldwide. We do not refer to these numbers because we have become accustomed to it. A universal vaccine like the one we produced will prevent many diseases, including avian influenza and swine flu, which never know when their new strain will arrive. And when such a vaccine, a new vaccine should not be prepared and vaccinated every year. "It will only be possible to give thrust shots once every few years, as they do with tetanus, for example."
Q/After so many years of research on the flu vaccine, do you believe you should see it happen?
A/"If the clinical trial succeeds, I think it will. It will take a few more months, and I believe I will live by then, if I do not like Corona. It will give me great satisfaction. It can benefit humanity for years."
Q/How will you feel if the experiment fails?
A/"I don't want to think about it."
Recent BVXV News
- Form NT 20-F - Notification of inability to timely file Form 20-F • Edgar (US Regulatory) • 04/30/2024 08:06:46 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/16/2024 09:27:06 PM
- Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG • PR Newswire (US) • 04/10/2024 11:00:00 AM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 03/12/2024 08:17:13 PM
- Scinai leadership to attend BIO-Europe Spring 2024 • PR Newswire (US) • 03/12/2024 12:00:00 PM
- Scinai Welcomes Liat Halpert as Head of Business Development and Sales • PR Newswire (US) • 02/13/2024 12:00:00 PM
- Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds • PR Newswire (US) • 01/04/2024 09:01:00 PM
- Scinai Immunotherapeutics Regains Compliance with Nasdaq's Stockholders' Equity Rule • PR Newswire (US) • 11/20/2023 12:30:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM